Clinical Trials Browser

INDUSTRY × Carcinoma × Sunitinib × Clear all

NCT03091192 2026-01-23

Savolitinib vs. Sunitinib in MET-driven PRCC.

Phase 3 Active not recruiting

60 enrolled 15 charts

Carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms by Site, Urologic Neoplasms

NCT05043090 2025-05-08

SAMETA

Phase 3 Active not recruiting

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT04033991 2023-04-06

Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

684 enrolled 20 charts

Carcinoma, Neoplasms

NCT01525550 2019-07-30

A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Phase 4 Completed

106 enrolled 26 charts

EndocrineGastrointestinalNET

Adenoma, Carcinoma, Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors

NCT00137423 2009-09-30

Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer

Phase 2 Completed

107 enrolled 15 charts

Carcinoma

NCT00092001 2008-10-16

Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Carcinoma, Non-Small-Cell Lung